Psyence Biomedical Ltd. Common Shares (PBM) — Financial Flexibility Index
Psyence Biomedical Ltd. Common Shares (PBM) has a Financial Flexibility Index of -0.05x as of December 2023. Free cash flow of $-658.20 (operating CF $-662.00 minus capex $3.80) represents 0% of total liabilities ($12.10K). Check PBM goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Psyence Biomedical Ltd. Common Shares Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Psyence Biomedical Ltd. Common Shares across 4 annual periods. For the full cash flow conversion analysis, see Psyence Biomedical Ltd. Common Shares cash flow conversion.
Annual Financial Flexibility Index for Psyence Biomedical Ltd. Common Shares (2022–2025)
Year-by-year free cash flow to debt coverage for Psyence Biomedical Ltd. Common Shares. Explore PBM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.27x | $-3.72 Million | $-3.73 Million | $594.37K | ▼ -2480.2% |
| 2024 | -0.24x | $-2.94 Million | $-2.95 Million | $12.10 Million | ▼ -567.0% |
| 2023 | -0.04x | $-519.60K | $-519.60K | $14.27 Million | ▲ +57.3% |
| 2022 | -0.09x | $-1.40 Million | $-1.40 Million | $16.38 Million | — |